United States Immunotherapy Drugs Market Report 2016

Publisher Name :
Date: 14-Sep-2016
No. of pages: 118
Inquire Before Buying

Notes:

Sales, means the sales volume of Immunotherapy Drugs

Revenue, means the sales value of Immunotherapy Drugs

This report studies sales (consumption) of Immunotherapy Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Merck-Pfizer

- Eli Lilly

- Amgen

- Roche

- Bristol Myers Squibb

- Dendreon (Valeant)

- Novartis

- Seattle Genetics

- Celgene

- AstraZeneca

- Northwest Biotherapeutics

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Specific Cancer Immunotherapy Drugs

- Non-Specific Cancer Immunotherapy Drugs

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Immunotherapy Drugs in each application, can be divided into

- Leukemia Treatment

- Colorectal Cancer Treatment

- Other Cancer Treatment

United States Immunotherapy Drugs Market Report 2016

Table of Contents
United States Immunotherapy Drugs Market Report 2016
1 Immunotherapy Drugs Overview
1.1 Product Overview and Scope of Immunotherapy Drugs
1.2 Classification of Immunotherapy Drugs
1.2.1 Specific Cancer Immunotherapy Drugs
1.2.2 Non-Specific Cancer Immunotherapy Drugs
1.2.3 Type III
1.3 Application of Immunotherapy Drugs
1.3.1 Leukemia Treatment
1.3.2 Colorectal Cancer Treatment
1.3.3 Other Cancer Treatment
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Immunotherapy Drugs (2011-2021)
1.4.1 United States Immunotherapy Drugs Sales and Growth Rate (2011-2021)
1.4.2 United States Immunotherapy Drugs Revenue and Growth Rate (2011-2021)
2 United States Immunotherapy Drugs Competition by Manufacturers
2.1 United States Immunotherapy Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Immunotherapy Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Immunotherapy Drugs Average Price by Manufactures (2015 and 2016)
2.4 Immunotherapy Drugs Market Competitive Situation and Trends
2.4.1 Immunotherapy Drugs Market Concentration Rate
2.4.2 Immunotherapy Drugs Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Immunotherapy Drugs Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Immunotherapy Drugs Sales and Market Share by Type (2011-2016)
3.2 United States Immunotherapy Drugs Revenue and Market Share by Type (2011-2016)
3.3 United States Immunotherapy Drugs Price by Type (2011-2016)
3.4 United States Immunotherapy Drugs Sales Growth Rate by Type (2011-2016)
4 United States Immunotherapy Drugs Sales (Volume) by Application (2011-2016)
4.1 United States Immunotherapy Drugs Sales and Market Share by Application (2011-2016)
4.2 United States Immunotherapy Drugs Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Immunotherapy Drugs Manufacturers Profiles/Analysis
5.1 Merck-Pfizer
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Immunotherapy Drugs Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Merck-Pfizer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Eli Lilly
5.2.2 Immunotherapy Drugs Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Eli Lilly Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Amgen
5.3.2 Immunotherapy Drugs Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Amgen Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Roche
5.4.2 Immunotherapy Drugs Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Roche Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Bristol Myers Squibb
5.5.2 Immunotherapy Drugs Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Bristol Myers Squibb Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Dendreon (Valeant)
5.6.2 Immunotherapy Drugs Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Dendreon (Valeant) Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Novartis
5.7.2 Immunotherapy Drugs Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Novartis Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Seattle Genetics
5.8.2 Immunotherapy Drugs Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Seattle Genetics Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Celgene
5.9.2 Immunotherapy Drugs Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Celgene Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 AstraZeneca
5.10.2 Immunotherapy Drugs Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 AstraZeneca Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Northwest Biotherapeutics
6 Immunotherapy Drugs Manufacturing Cost Analysis
6.1 Immunotherapy Drugs Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Immunotherapy Drugs
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Immunotherapy Drugs Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Immunotherapy Drugs Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Immunotherapy Drugs Market Forecast (2016-2021)
10.1 United States Immunotherapy Drugs Sales, Revenue Forecast (2016-2021)
10.2 United States Immunotherapy Drugs Sales Forecast by Type (2016-2021)
10.3 United States Immunotherapy Drugs Sales Forecast by Application (2016-2021)
10.4 Immunotherapy Drugs Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Immunotherapy Drugs
Table Classification of Immunotherapy Drugs
Figure United States Sales Market Share of Immunotherapy Drugs by Type in 2015
Figure Specific Cancer Immunotherapy Drugs Picture
Figure Non-Specific Cancer Immunotherapy Drugs Picture
Table Application of Immunotherapy Drugs
Figure United States Sales Market Share of Immunotherapy Drugs by Application in 2015
Figure Leukemia Treatment Examples
Figure Colorectal Cancer Treatment Examples
Figure Other Cancer Treatment Examples
Figure United States Immunotherapy Drugs Sales and Growth Rate (2011-2021)
Figure United States Immunotherapy Drugs Revenue and Growth Rate (2011-2021)
Table United States Immunotherapy Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Immunotherapy Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Immunotherapy Drugs Sales Share by Manufacturers
Figure 2016 Immunotherapy Drugs Sales Share by Manufacturers
Table United States Immunotherapy Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Immunotherapy Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Immunotherapy Drugs Revenue Share by Manufacturers
Table 2016 United States Immunotherapy Drugs Revenue Share by Manufacturers
Table United States Market Immunotherapy Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Immunotherapy Drugs Average Price of Key Manufacturers in 2015
Figure Immunotherapy Drugs Market Share of Top 3 Manufacturers
Figure Immunotherapy Drugs Market Share of Top 5 Manufacturers
Table United States Immunotherapy Drugs Sales by Type (2011-2016)
Table United States Immunotherapy Drugs Sales Share by Type (2011-2016)
Figure United States Immunotherapy Drugs Sales Market Share by Type in 2015
Table United States Immunotherapy Drugs Revenue and Market Share by Type (2011-2016)
Table United States Immunotherapy Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Immunotherapy Drugs by Type (2011-2016)
Table United States Immunotherapy Drugs Price by Type (2011-2016)
Figure United States Immunotherapy Drugs Sales Growth Rate by Type (2011-2016)
Table United States Immunotherapy Drugs Sales by Application (2011-2016)
Table United States Immunotherapy Drugs Sales Market Share by Application (2011-2016)
Figure United States Immunotherapy Drugs Sales Market Share by Application in 2015
Table United States Immunotherapy Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Immunotherapy Drugs Sales Growth Rate by Application (2011-2016)
Table Merck-Pfizer Basic Information List
Table Merck-Pfizer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck-Pfizer Immunotherapy Drugs Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly Immunotherapy Drugs Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Immunotherapy Drugs Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Immunotherapy Drugs Sales Market Share (2011-2016)
Table Bristol Myers Squibb Basic Information List
Table Bristol Myers Squibb Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol Myers Squibb Immunotherapy Drugs Sales Market Share (2011-2016)
Table Dendreon (Valeant) Basic Information List
Table Dendreon (Valeant) Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dendreon (Valeant) Immunotherapy Drugs Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Immunotherapy Drugs Sales Market Share (2011-2016)
Table Seattle Genetics Basic Information List
Table Seattle Genetics Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Seattle Genetics Immunotherapy Drugs Sales Market Share (2011-2016)
Table Celgene Basic Information List
Table Celgene Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celgene Immunotherapy Drugs Sales Market Share (2011-2016)
Table AstraZeneca Basic Information List
Table AstraZeneca Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca Immunotherapy Drugs Sales Market Share (2011-2016)
Table Northwest Biotherapeutics Basic Information List
Table Northwest Biotherapeutics Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Northwest Biotherapeutics Immunotherapy Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Immunotherapy Drugs
Figure Manufacturing Process Analysis of Immunotherapy Drugs
Figure Immunotherapy Drugs Industrial Chain Analysis
Table Raw Materials Sources of Immunotherapy Drugs Major Manufacturers in 2015
Table Major Buyers of Immunotherapy Drugs
Table Distributors/Traders List
Figure United States Immunotherapy Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Immunotherapy Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Immunotherapy Drugs Production Forecast by Type (2016-2021)
Table United States Immunotherapy Drugs Consumption Forecast by Application (2016-2021)
  • Global Enzymatic Debridement Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 15-Jun-2018        Price: US 3480 Onwards        Pages: 129
    Enzymatic Debridement uses chemical enzymes to assist in wound healing. Enzymes that help slough off the dead tissue are often available as part of a topic ointment; however, the ointment must be carefully applied to only the currently dead tissue - if the enzymes come in contact with healthy tissue, they could cause issues. Scope of the Report: This report focuses on the Enzymatic Debridement in global market, especially in North America, Europe and Asia-Pacific, South Ame......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Enzymatic Debridement Market 2018, Forecast to 2023
    Published: 15-Jun-2018        Price: US 4880 Onwards        Pages: 133
    Enzymatic Debridement uses chemical enzymes to assist in wound healing. Enzymes that help slough off the dead tissue are often available as part of a topic ointment; however, the ointment must be carefully applied to only the currently dead tissue - if the enzymes come in contact with healthy tissue, they could cause issues. Scope of the Report: This report focuses on the Enzymatic Debridement in global market, especially in North America, Europe and Asia-Pacific, South Ame......
  • Global Vaccine Market, People Vaccinated, Administered, Immunization, By Disease, By End User, Companies
    Published: 14-Jun-2018        Price: US 1990 Onwards        Pages: 355
    Global Vaccine Market is projected to reach US$ 70 Billion by the year 2024. The vaccine market is likely to witness a significant growth throughout the forecast period due to the growing prevalence of diseases, increasing government and non-government funding for vaccine development & distribution and increasing investments by companies to develop new vaccines. Furthermore, growing demand for preventive vaccines, rising consciousness about vaccination coupled with mounting demand from th......
  • Global Celery Seed Extract Solid Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 13-Jun-2018        Price: US 3480 Onwards        Pages: 135
    Celery seed solid extract and oil are majorly used for healthcare benefits as anti-spasmodic, nerve stimulant, stimulant and tonic in asthma, rheumatoid arthritis, intestinal antiseptic. The essential oil of celery seed comprise of sesquiterpene alcohols, sedanolide, d-limonene, selinene, and sedanonic anhydride. Celery oil is mostly used for flavoring of food and perfumes. Scope of the Report: This report focuses on the Celery Seed Extract Solid in global market, especial......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Celery Seed Extract Solid Market 2018, Forecast to 2023
    Published: 13-Jun-2018        Price: US 4880 Onwards        Pages: 128
    Celery seed solid extract and oil are majorly used for healthcare benefits as anti-spasmodic, nerve stimulant, stimulant and tonic in asthma, rheumatoid arthritis, intestinal antiseptic. The essential oil of celery seed comprise of sesquiterpene alcohols, sedanolide, d-limonene, selinene, and sedanonic anhydride. Celery oil is mostly used for flavoring of food and perfumes. Scope of the Report: This report focuses on the Celery Seed Extract Solid in global market, especial......
  • Globoid Cell Leukodystrophy (Krabbe Disease) - Pipeline Review, H1 2018
    Published: 12-Jun-2018        Price: US 2000 Onwards        Pages: 49
    Globoid Cell Leukodystrophy (Krabbe Disease) - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Globoid Cell Leukodystrophy (Krabbe Disease) - Pipeline Review, H1 2018, provides an overview of the Globoid Cell Leukodystrophy (Krabbe Disease) (Central Nervous System) pipeline landscape. Krabbe disease also called globoid cell leukodystrophy is a degenerative disorder caused by the deficiency......
  • Dental Pain - Pipeline Review, H1 2018
    Published: 12-Jun-2018        Price: US 2000 Onwards        Pages: 35
    Dental Pain - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dental Pain - Pipeline Review, H1 2018, provides an overview of the Dental Pain (Central Nervous System) pipeline landscape. A pain in the tooth is called dental pain. This can be caused by tooth decay, damaged filling, tooth fracture, etc. Symptoms of a toothache may include: tooth pain that may be sharp, throbbing, or constant......
  • Canavan Disease - Pipeline Review, H1 2018
    Published: 12-Jun-2018        Price: US 2000 Onwards        Pages: 28
    Canavan Disease - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Canavan Disease - Pipeline Review, H1 2018, provides an overview of the Canavan Disease (Central Nervous System) pipeline landscape. Canavan disease is a gene-linked neurological disorder in which the brain degenerates into spongy tissue riddled with microscopic fluid-filled spaces. Cause includes a mutation in the gene whic......
  • Encephalopathy - Pipeline Review, H1 2018
    Published: 12-Jun-2018        Price: US 2000 Onwards        Pages: 78
    Encephalopathy - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Encephalopathy - Pipeline Review, H1 2018, provides an overview of the Encephalopathy (Central Nervous System) pipeline landscape. Encephalopathy is a term for any diffuse disease of the brain that alters brain function or structure. Symptoms include seizures, difficulty speaking or swallowing, trembling, involuntary twitchin......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs